HealthLawProf Blog

Editor: Katharine Van Tassel
Case Western Reserve University School of Law

Sunday, October 24, 2021

How the Politics of Big Pharma Is Undermining COVID-19 Public Health Policy in Canada

Claudia Chaufan (York University), Faisal Mohamed (York University), How the Politics of Big Pharma Is Undermining COVID-19 Public Health Policy in Canada, SSRN (2021):

In December 2020 a former NATO commander in Iraq appointed to lead vaccination logistics in the Public Health Agency of Canada announced that the country would adopt a “whole-of-nation” approach to achieve the goal of vaccinating all Canadians by the summer. Two months away from the summer, four into the announcement, and with 400 million doses procured to vaccinate 38 million people several times over, less than 3% of Canadians have received two doses of the leading, authorized products. 

A range of explanations have been proffered for the delay, including that the Liberal Trudeau Government is treating Big Pharma unfairly, thus causing unnecessary barriers to vaccine supplies. We argue that the assertion does not stand up to scrutiny. As our analysis will show, Canadian pharmaceutical policy is extremely corporate friendly and has been so for decades. This has led to both a predictably rocky vaccine effort and to the continuing failure by the government to guarantee equitable access to medically necessary drugs, prior to, during, and beyond the COVID-19 pandemic.

https://lawprofessors.typepad.com/healthlawprof_blog/2021/10/how-the-politics-of-big-pharma-is-undermining-covid-19-public-health-policy-in-canada.html

| Permalink

Comments